financetom
Business
financetom
/
Business
/
RecycLiCo Battery Materials Obtains European Unitary Patent for Battery Recycling Process
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RecycLiCo Battery Materials Obtains European Unitary Patent for Battery Recycling Process
Jul 16, 2024 4:08 AM

06:52 AM EDT, 07/16/2024 (MT Newswires) -- RecycLiCo Battery Materials ( AMYZF ) on Monday said it has been granted a European Unitary Patent for its hydrometallurgical lithium-ion battery recycling solution.

The patent solidifies the company's intellectual property portfolio in Europe, a key market focused on electrification and sustainable battery technologies, RecycLiCo said.

The patent is the 16th issued globally for the company. It also holds patents in the U.S., South Korea, Japan, China, India, Australia and Canada.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Roivant Sciences Insider Sold Shares Worth $5,648,000, According to a Recent SEC Filing
Roivant Sciences Insider Sold Shares Worth $5,648,000, According to a Recent SEC Filing
Mar 20, 2026
04:24 AM EDT, 03/20/2026 (MT Newswires) -- Eric Venker, President and Immunovant Chief Executive Officer, on March 17, 2026, sold 200,000 shares in Roivant Sciences ( ROIV ) for $5,648,000. Following the Form 4 filing with the SEC, Venker has control over a total of 1,647,546 common shares of the company, with 1,647,546 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1635088/000163508826000026/xslF345X05/wk-form4_1773959801.xml ...
Cytomx Therapeutics Insider Sold Shares Worth $764,138, According to a Recent SEC Filing
Cytomx Therapeutics Insider Sold Shares Worth $764,138, According to a Recent SEC Filing
Mar 20, 2026
04:25 AM EDT, 03/20/2026 (MT Newswires) -- Sean A. McCarthy, Director and Chief Executive Officer, on March 17, 2026, sold 118,969 shares in Cytomx Therapeutics ( CTMX ) for $764,138. Following the Form 4 filing with the SEC, McCarthy has control over a total of 1,172,080 common shares of the company, with 1,078,922 shares held directly and 93,158 controlled indirectly....
Alignment Healthcare Insider Sold Shares Worth $274,040, According to a Recent SEC Filing
Alignment Healthcare Insider Sold Shares Worth $274,040, According to a Recent SEC Filing
Mar 20, 2026
04:26 AM EDT, 03/20/2026 (MT Newswires) -- Sebastian Burzacchi, Chief Operating Officer of Management Services Organization, on March 18, 2026, sold 15,361 shares in Alignment Healthcare ( ALHC ) for $274,040. Following the Form 4 filing with the SEC, Burzacchi has control over a total of 258,630 common shares of the company, with 258,630 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1832466/000162828026019921/xslF345X05/wk-form4_1773960255.xml...
Market Chatter: Novo Nordisk Weight-Loss Patents Set to Expire, Paving Way for Cheap Generics
Market Chatter: Novo Nordisk Weight-Loss Patents Set to Expire, Paving Way for Cheap Generics
Mar 20, 2026
04:24 AM EDT, 03/20/2026 (MT Newswires) -- Novo Nordisk's ( NVO ) weight-loss drugs in India are about to face steep price cuts after the introduction of generic versions this month with the expiration of patents, Bloomberg reported Friday. At least 12 companies are expected to immediately launch injectable versions of semaglutide with prices as low as 1,290 ($13.82) rupees...
Copyright 2023-2026 - www.financetom.com All Rights Reserved